75 related articles for article (PubMed ID: 26529072)
1. A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice.
Jiang L; Fan R; Sun S; Fan P; Su W; Zhou Y; Gao F; Xu F; Kong W; Jiang C
Vaccine; 2015 Nov; 33(48):6596-603. PubMed ID: 26529072
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease.
Maje Bello A; Chaimongkolnukul K; Poomputsa K; Mekvichitsaeng P; Maprang Roshorm Y
Vaccine; 2024 Jun; 42(17):3733-3743. PubMed ID: 38705805
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71.
Huang KA; Zhou D; Fry EE; Kotecha A; Huang PN; Yang SL; Tsao KC; Huang YC; Lin TY; Ren J; Stuart DI
Nat Commun; 2020 Oct; 11(1):5253. PubMed ID: 33067459
[TBL] [Abstract][Full Text] [Related]
4. A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus.
Xia M; Wei C; Wang L; Cao D; Meng XJ; Jiang X; Tan M
Vaccine; 2016 Feb; 34(7):905-13. PubMed ID: 26778421
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Characterization of Neutralizing Hen Antibodies to
Mwale PF; Lee CH; Huang PN; Tseng SN; Shih SR; Huang HY; Leu SJ; Huang YJ; Chiang LC; Mao YC; Wang WC; Yang YY
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923724
[No Abstract] [Full Text] [Related]
6. A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies.
Atmar RL; Ettayebi K; Ramani S; Neill FH; Lindesmith L; Baric RS; Brinkman A; Braun R; Sherwood J; Estes MK
J Infect Dis; 2024 May; 229(5):1402-1407. PubMed ID: 37781879
[TBL] [Abstract][Full Text] [Related]
7. Enterovirus virus-like-particle and inactivated poliovirus vaccines do not elicit substantive cross-reactive antibody responses.
Moss DL; Paine AC; Krug PW; Kanekiyo M; Ruckwardt TJ
PLoS Pathog; 2024 Apr; 20(4):e1012159. PubMed ID: 38662650
[TBL] [Abstract][Full Text] [Related]
8. Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics.
Sharon J; Rynkiewicz MJ; Lu Z; Yang CY
Immunology; 2014 May; 142(1):1-23. PubMed ID: 24219801
[TBL] [Abstract][Full Text] [Related]
9. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease.
Ong KC; Devi S; Cardosa MJ; Wong KT
J Virol; 2010 Jan; 84(1):661-5. PubMed ID: 19864378
[TBL] [Abstract][Full Text] [Related]
10. Monitoring antigenic variations of enterovirus 71: implications for virus surveillance and vaccine development.
Chia MY; Chung WY; Chiang PS; Chien YS; Ho MS; Lee MS
PLoS Negl Trop Dis; 2014 Jul; 8(7):e3044. PubMed ID: 25058733
[TBL] [Abstract][Full Text] [Related]
11. Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid.
Parker TD; Kitamoto N; Tanaka T; Hutson AM; Estes MK
J Virol; 2005 Jun; 79(12):7402-9. PubMed ID: 15919896
[TBL] [Abstract][Full Text] [Related]
12. Forecasting the economic value of an Enterovirus 71 (EV71) vaccine.
Lee BY; Wateska AR; Bailey RR; Tai JH; Bacon KM; Smith KJ
Vaccine; 2010 Nov; 28(49):7731-6. PubMed ID: 20923711
[TBL] [Abstract][Full Text] [Related]
13. Thermal stability and epitope integrity of a lyophilized ricin toxin subunit vaccine.
Westfall J; Yates JL; Van Slyke G; Ehrbar D; Measey T; Straube R; Donini O; Mantis NJ
Vaccine; 2018 Sep; 36(40):5967-5976. PubMed ID: 30172637
[TBL] [Abstract][Full Text] [Related]
14. Self-Assembled Multi-Epitope Peptide Amphiphiles Enhance the Immune Response against Enterovirus 71.
Kim YG; Lee Y; Kim JH; Chang SY; Jung JW; Chung WJ; Jin HE
Nanomaterials (Basel); 2020 Nov; 10(12):. PubMed ID: 33255791
[TBL] [Abstract][Full Text] [Related]
15. EpIC: a rational pipeline for epitope immunogenicity characterization.
Marciniuk K; Trost B; Napper S
Bioinformatics; 2015 Jul; 31(14):2388-90. PubMed ID: 25750418
[TBL] [Abstract][Full Text] [Related]
16. Computational Prediction of Potential Vaccine Candidates From tRNA Encoded peptides (tREP) Using a Bioinformatic Workflow and Molecular Dynamics Validations.
Shanthappa PM; Verma N; George A; Dhar PK; Athri P
IEEE/ACM Trans Comput Biol Bioinform; 2024; 21(3):439-449. PubMed ID: 38427544
[TBL] [Abstract][Full Text] [Related]
17. Structure determination of enterovirus 71.
Plevka P; Perera R; Cardosa J; Kuhn RJ; Rossmann MG
Acta Crystallogr D Biol Crystallogr; 2012 Sep; 68(Pt 9):1217-22. PubMed ID: 22948923
[TBL] [Abstract][Full Text] [Related]
18. Virus-like Particle Vaccines and Platforms for Vaccine Development.
Kheirvari M; Liu H; Tumban E
Viruses; 2023 May; 15(5):. PubMed ID: 37243195
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled multiepitope nanovaccine based on NoV P particles induces effective and lasting protection against H3N2 influenza virus.
Nie J; Wang Q; Jin S; Yao X; Xu L; Chang Y; Ding F; Li Z; Sun L; Shi Y; Shan Y
Nano Res; 2023; 16(5):7337-7346. PubMed ID: 36820263
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and evolution of Norovirus in China.
Wei N; Ge J; Tan C; Song Y; Wang S; Bao M; Li J
Hum Vaccin Immunother; 2021 Nov; 17(11):4553-4566. PubMed ID: 34495811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
